|1.||Zhao, Gang: 10 articles (07/2014 - 10/2008)|
|2.||Ye, Ruidong: 7 articles (07/2014 - 10/2008)|
|3.||Shi, Ming: 6 articles (07/2014 - 02/2011)|
|4.||Han, Junliang: 6 articles (07/2014 - 10/2008)|
|5.||Zhang, Yunxia: 5 articles (07/2014 - 02/2011)|
|6.||Kong, Xiangwei: 4 articles (09/2011 - 10/2008)|
|7.||Xiong, Lize: 3 articles (07/2014 - 02/2011)|
|8.||Zhang, Xiao: 3 articles (07/2014 - 02/2011)|
|9.||Wu, Yong-Jie: 3 articles (12/2013 - 02/2012)|
|10.||Zhao, G: 3 articles (06/2012 - 05/2009)|
07/01/2011 - "Ginsenoside rd in experimental stroke: superior neuroprotective efficacy with a wide therapeutic window."
06/01/2012 - " Ginsenoside-Rd improved the primary outcome of acute ischaemic stroke and had an acceptable adverse-event profile."
01/01/2012 - "Our previous studies have demonstrated that ginsenoside Rd (GSRd), one of the principal ingredients of Pana notoginseng, has neuroprotective effects against ischemic stroke. "
09/15/2014 - "Ginsenoside Rd has a clear neuroprotective effect against ischemic stroke. "
06/01/2013 - "Ginsenoside Rd for acute ischemic stroke: translating from bench to bedside."
|2.||Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
09/01/2014 - "Ginsenoside Rd ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice."
09/01/2014 - "In this study, we explore the efficacy of ginsenoside Rd in experimental autoimmune encephalomyelitis (EAE), an established model of MS. EAE was induced by myelin oligodendrocyte glycoprotein 35-55-amino-acid peptide. "
04/01/2015 - "To investigate the effects of ginsenoside Rd (Rd) on neurogenesis in rat brain after ischemia/reperfusion injury (IRI). "
09/15/2014 - "Intraperitoneal injection of ginsenoside Rd in ischemia/reperfusion injury rats not only improved hindlimb motor function and the morphology of motor neurons in the anterior horn of the spinal cord, but it also reduced neuronal apoptosis. "
01/01/2015 - "Ginsenoside Rd mitigates myocardial ischemia-reperfusion injury via Nrf2/HO-1 signaling pathway."
09/15/2014 - "We aimed to verify the neuroprotective effect of ginsenoside Rd in spinal cord ischemia/reperfusion injury and explore its anti-apoptotic mechanisms. "
09/15/2014 - "Ginsenoside Rd inhibits apoptosis following spinal cord ischemia/reperfusion injury."
01/01/1998 - "A study of ginsenoside-Rd in a renal ischemia-reperfusion model."
01/01/2015 - "Ginsenoside Rd (GsRd) reportedly protects the heart against ischemia-reperfusion (I/R) injury. "
09/15/2014 - "The optimal dose of ginsenoside Rd was 25 mg/kg per day and the optimal time point was 5 days after ischemia/reperfusion. "
03/31/2011 - "Ginsenoside Rd attenuates mitochondrial dysfunction and sequential apoptosis after transient focal ischemia."
02/01/2011 - "Ginsenoside Rd attenuates early oxidative damage and sequential inflammatory response after transient focal ischemia in rats."
|5.||Brain Ischemia (Cerebral Ischemia)
12/01/2013 - "Our previous clinical and basic studies have demonstrated that ginsenoside Rd (GS-Rd) has remarkable neuroprotective effects after cerebral ischemia but the underlying mechanisms are still unknown. "
04/01/2015 - "Ginsenoside Rd promotes neurogenesis in rat brain after transient focal cerebral ischemia via activation of PI3K/Akt pathway."
10/01/2012 - "Ginsenoside-Rd attenuates TRPM7 and ASIC1a but promotes ASIC2a expression in rats after focal cerebral ischemia."
09/01/2011 - "Ginsenoside Rd attenuates redox imbalance and improves stroke outcome after focal cerebral ischemia in aged mice."
12/01/2013 - "Ginsenoside Rd blocks AIF mitochondrio-nuclear translocation and NF-κB nuclear accumulation by inhibiting poly(ADP-ribose) polymerase-1 after focal cerebral ischemia in rats."
|4.||Apolipoproteins E (ApoE)
|9.||Proteins (Proteins, Gene)
|3.||Surgical Instruments (Clip)